Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera (PEGINVERA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01193699
Recruitment Status : Completed
First Posted : September 2, 2010
Last Update Posted : January 30, 2018
Information provided by (Responsible Party):
AOP Orphan Pharmaceuticals AG